Australia's most trusted
source of pharma news
Posted 6 November 2025 PM
Sandoz has snapped up four prizes – including Company of the Year – at the Global Generics & Biosimilars Awards 2025.
The former Novartis division, which became a standalone company two years ago, picked up the top honour at an awards ceremony in Frankfurt last week, with judges noting that it had delivered on key milestones, launched flagship biosimilars, announced investments of more than US$1 billion and taken a leading role in fighting originator intellectual property abuses.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.